Transcranial Magnetic Stimulation for Treatment of Methamphetamine Dependence
Launched by SHANGHAI MENTAL HEALTH CENTER · Jan 30, 2019
Trial Information
Current as of June 19, 2025
Completed
Keywords
ClinConnect Summary
First, a multicenter, double-blind, randomized control study is going to be carried out. 100 recruited patients will be randomized assigned to the intervention group and the control group, receiving either 4-week of repetitive transcranial magnetic stimulation (rTMS) treatment or 4-week of sham rTMS treatment. Both groups will receive 12-week urine drug test follow-up (1 time per week). Negative rate of urine test during the follow-up period is set as primary outcome. Cognitive function, craving, depression are also evaluated before and after the intervention.
Secondly, another 40 patients...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders
- • 2. Junior high school degree or above
- • 3. Normal vision and hearing
- • 4. Dextromanual
- • 5. Less than one month before last drug use
- Exclusion Criteria:
- • 1. Have a disease that affect cognitive function such as history of head injury, cerebrovascular disease, epilepsy, etc
- • 2. Have cognitive-promoting drugs in the last 6 months
- • 3. Other substance abuse or dependence in recent five years (except nicotine)
- • 4. Mental impairment, Intelligence Quotient (IQ) \< 70
- • 5. Mental disorders
- • 6. Physical disease
About Shanghai Mental Health Center
Shanghai Mental Health Center is a leading institution dedicated to advancing mental health research and treatment. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and evidence-based practices to address a wide range of psychiatric disorders. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to enhancing patient care through rigorous clinical trials that contribute to the understanding and management of mental health conditions. Its mission is to foster collaboration among researchers, clinicians, and patients to promote mental well-being and improve outcomes in mental health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Haifeng Jiang
Principal Investigator
Shanghai Mental Health Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials